DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Taltz is a prescription medication that targets interleukin-17A, an inflammatory protein and is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.